⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 15, 2012Gut and LiverOpen Access

Epigallocatechin-3-gallate Inhibits LPS-Induced NF-κB and MAPK Signaling Pathways in Bone Marrow-Derived Macrophages

So Young Joo Young-A Song Young-Lan Park Eun Myung Cho‐Yun Chung Kang-Jin Park Sung Bum Cho Wan‐Sik Lee Hyun Soo Kim Jong‐Sun Rew Nack-Sung Kim Young‐Eun Joo

View Full Paper

Ask AI

Bookmark

Share

Abstract

These results indicate that EGCG may prevent LPS-induced pro-inflammatory gene expression through blocking NF-κB and MAPK signaling pathways in BMMs.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Joo et al. (2012) studied this question.

synapsesocial.com/papers/69dd496f2f737f012599b7fb https://doi.org/10.5009/gnl.2012.6.2.188

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Targeting Multiple Signaling Pathways by Green Tea Polyphenol (−)-Epigallocatechin-3-GallateReview · 2006 · 818 citations
2The fundamental basis of inflammatory bowel diseaseOriginal Research · 2007 · 1,319 citations
3Role of cytokines in inflammatory bowel diseaseOriginal Research · 2008 · 697 citations
4The key role of macrophages in the immunopathogenesis of inflammatory bowel diseaseOriginal Research · 2007 · 57 citations
5In Vivo Pattern of Lipopolysaccharide and Anti-CD3-Induced NF-κB Activation Using a Novel Gene-Targeted Enhanced GFP Reporter Gene MouseOriginal Research · 2004 · 113 citations

More related papers

NF-κB and the intestine: Friend or foe?2007
Signaling to NF-κB2004
The MAPK signaling cascade1995

More from Gut and Liver

A Terpene Preparation for the Pharmacological Prevention of Common Bile Duct Stone Recurrence after Endoscopic Clearance: A Randomized Pilot TrialTue,
Nationwide Claims-Based Incidence and Associated Factors of Adverse Events after Gastric Endoscopic Submucosal DissectionTue,